Yale team identifies successful combination drug therapies for melanoma mutations

Really? 

They found that combining statins with drugs that inhibited cyclin-dependent protein kinase enzymes, which regulate and promote the cellular growth of cancer, produced a similar response with both RAS- and BRAF-mutated oncogenes.

http://news.yale.edu/2012/12/13/yale-team-identifies-successful-combination-drug-therapies-melanoma-mutations